Richard Moriggl

Has grant

Prof.

University of Veterinary Medicine Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Prof. Richard Moriggl is a faculty member at Veterinary University Vienna, Austria. His research primarily focuses on acute myeloid leukemia, cellular signaling, and the role of immune cells in cancer. Recent publications highlight his work on STAT signaling pathways, drug efficacy in leukemia treatment, and the metabolic implications of hematocrit levels. He is also involved in advancing medicinal chemistry related to histone deacetylases and lymphocyte-related malignancies.

Recent Grants

Grant: Close

Implementation of (epi)genetic and metabolic networks in the targeting of T-cell prolymphocytic leukemia

Open Date: 2019-07-01

Close Date: 2022-06-01

Grant: Close

Chromatin remodelling through oncogenic STAT5 in Peripheral T-Cell Leukemia and Lymphoma

Open Date: 2017-03-01

Close Date: 2021-03-01

Grant: Close

Cancer Metabolism

Open Date: 2016-12-01

Close Date: 2019-12-01

Grant: Close

STAT3/5 inhibitors

Open Date: 2016-05-01

Close Date: 2019-05-01

Grant: Close

Targeting STAT5

Open Date: 2013-01-01

Close Date: 2021-01-01

Articles (13)

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (18)

Johannes Schmoellerl

Research Institute of Molecular Pathology

AUSTRIA

Richard Moriggl

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (13)

A direct effect of the hematocrit on blood glucose: Evidence from hypoxia- and erythropoietin-treated mice

Loss of STAT3 in Acute Myeloid Leukemia Favors Tissue Infiltration Linked to CXCR4 Signaling

Correction: Weber et al. Stat5 Exerts Distinct, Vital Functions in the Cytoplasm and Nucleus of Bcr-Abl+ K562 and Jak2(V617F)+ HEL Leukemia Cells. Cancers 2015, 7, 503–537

ABCC1 and glutathione metabolism limit the efficacy of BCL-2 inhibitors in acute myeloid leukemia

Medicinal chemistry advances in targeting class I histone deacetylases

High Efficacy and Drug Synergy of HDAC6-Selective Inhibitor NN-429 in Natural Killer (NK)/T-Cell Lymphoma

The Diverse Roles of γδ T Cells in Cancer: From Rapid Immunity to Aggressive Lymphoma

Efficacy and Synergy of Small Molecule Inhibitors Targeting FLT3-ITD+ Acute Myeloid Leukemia

STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation

Adipocyte STAT5 deficiency does not affect blood glucose homeostasis in obese mice

A Recurrent STAT5BN642H Driver Mutation in Feline Alimentary T Cell Lymphoma

A hydride transfer complex reprograms NAD metabolism and bypasses senescence.

A STAT5B-CD9 axis determines self-renewal in hematopoietic and leukemic stem cells.

Collaborators (18)

Johannes Schmoellerl

Michael N. Pollak

Heidi Neubauer

Karoline Kollmann

Gerhard Prager

Matthäus Metz

Patrick T. Gunning

Gergely Szakacs

Lisa Gensthaler

Thomas Scherer

Sophie Edtmayer

Martin Bilban

Diaaeldin I. Abdallah

Bishwa Ghimire

Jessica Ebner

Alexandra Kautzky-Willer

Vasileios Bekiaris

Daehong Kim

Make your next move.